couple of thoughts from me...
1. the ims data is in reference to prescription market share, not dollar value
2. i think the fonda prescription market has grown by about 26%. has anyone else come to that conclusion? i see acl earning a lot more than i had forecast now. a lot more.
sp and cash, page-42
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable